Physician profile
Joel D Stein
NPI 1831107036
$1,416.16
in general payments reported to CMS, 2019-2025
20 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Neuromusculoskeletal Medicine & Omm provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $112 · 2021: $424 · 2022: $131 · 2023: $100 · 2024: $147 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $323.69 | 2019-2022 | |
| Abbvie INC. | $221.78 | 2022-2025 | Botox |
| Gilead Sciences, INC. | $204.52 | 2019-2025 | Yeztugo |
| Depuy Synthes Sales INC. | $149.13 | 2019-2024 | Orthovisc |
| Electronic Waveform Lab, INC. | $102.38 | 2021 | |
| Ibsa Pharma INC. | $72.45 | 2020-2021 | |
| Orthogenrx INC. | $56.65 | 2019 | |
| Pacira Therapeutics, INC. | $35.88 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $35.69 | 2019 | |
| Convatec INC. | $30.53 | 2025 | |
| Djo, LLC | $26.22 | 2023 | Chattanooga |
| Amgen INC. | $25.75 | 2019-2021 | |
| Ermi LLC | $23.28 | 2020 | |
| Collegium Pharmaceutical, INC. | $18.55 | 2019 | |
| Pfizer INC. | $18.29 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $17.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.86 | 2022 | |
| Zimmer Biomet Holdings, INC. | $16.01 | 2022 | |
| Bioventus LLC | $14.69 | 2023 | Durolane |
| Amniox Medical, INC. | $6.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.